Concepts (57)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity, Morbid | 2 | 2022 | 96 | 0.860 |
Why?
|
| Laparoscopy | 3 | 2022 | 402 | 0.850 |
Why?
|
| Gastroplasty | 1 | 2021 | 14 | 0.760 |
Why?
|
| Gastric Bypass | 1 | 2021 | 74 | 0.720 |
Why?
|
| Specialties, Surgical | 1 | 2017 | 45 | 0.550 |
Why?
|
| Perioperative Care | 1 | 2017 | 79 | 0.540 |
Why?
|
| Hernia, Inguinal | 2 | 2021 | 38 | 0.370 |
Why?
|
| Robotic Surgical Procedures | 2 | 2021 | 112 | 0.320 |
Why?
|
| Anus Neoplasms | 2 | 2019 | 23 | 0.310 |
Why?
|
| Gastrectomy | 2 | 2022 | 38 | 0.230 |
Why?
|
| Esophagitis | 1 | 2022 | 9 | 0.200 |
Why?
|
| Opiate Alkaloids | 1 | 2021 | 1 | 0.190 |
Why?
|
| Hernia, Hiatal | 1 | 2022 | 26 | 0.190 |
Why?
|
| Gastroesophageal Reflux | 1 | 2022 | 84 | 0.190 |
Why?
|
| Reoperation | 1 | 2021 | 270 | 0.170 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 100 | 0.150 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1088 | 0.150 |
Why?
|
| Length of Stay | 2 | 2021 | 784 | 0.150 |
Why?
|
| Dendritic Cell Sarcoma, Interdigitating | 1 | 2017 | 1 | 0.140 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2018 | 88 | 0.140 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2019 | 240 | 0.140 |
Why?
|
| Clinical Protocols | 1 | 2017 | 139 | 0.130 |
Why?
|
| Rectal Neoplasms | 1 | 2017 | 99 | 0.130 |
Why?
|
| Recovery of Function | 1 | 2017 | 271 | 0.130 |
Why?
|
| Databases, Factual | 1 | 2018 | 855 | 0.120 |
Why?
|
| Melanoma | 1 | 2018 | 336 | 0.120 |
Why?
|
| Treatment Outcome | 2 | 2021 | 5347 | 0.110 |
Why?
|
| Patient Readmission | 1 | 2017 | 425 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2021 | 6192 | 0.100 |
Why?
|
| Quality Improvement | 1 | 2017 | 429 | 0.100 |
Why?
|
| Herniorrhaphy | 2 | 2021 | 65 | 0.090 |
Why?
|
| Humans | 8 | 2022 | 60912 | 0.090 |
Why?
|
| Postoperative Complications | 1 | 2017 | 1186 | 0.090 |
Why?
|
| Survival Rate | 2 | 2019 | 813 | 0.070 |
Why?
|
| Anesthesia, Local | 1 | 2021 | 20 | 0.050 |
Why?
|
| Bupivacaine | 1 | 2021 | 33 | 0.050 |
Why?
|
| Narcotics | 1 | 2021 | 53 | 0.050 |
Why?
|
| Postoperative Period | 1 | 2021 | 128 | 0.050 |
Why?
|
| Liposomes | 1 | 2021 | 100 | 0.050 |
Why?
|
| Anesthetics, Local | 1 | 2021 | 69 | 0.050 |
Why?
|
| Operative Time | 1 | 2021 | 68 | 0.050 |
Why?
|
| Surgical Mesh | 1 | 2021 | 58 | 0.050 |
Why?
|
| Analgesics | 1 | 2021 | 101 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2021 | 134 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2021 | 306 | 0.040 |
Why?
|
| Salvage Therapy | 1 | 2019 | 74 | 0.040 |
Why?
|
| Chemoradiotherapy | 1 | 2019 | 50 | 0.040 |
Why?
|
| Male | 4 | 2022 | 28424 | 0.040 |
Why?
|
| Rectum | 1 | 2017 | 86 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 510 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 1629 | 0.030 |
Why?
|
| Aged | 2 | 2019 | 13873 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 2401 | 0.030 |
Why?
|
| Middle Aged | 2 | 2019 | 16857 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 5289 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 4430 | 0.020 |
Why?
|
| Female | 2 | 2019 | 31706 | 0.020 |
Why?
|